Herrmann T, Jakubek A, Trott K R
Department of Radiotherapy, Medical Faculty Carl Gustav Carus, Technical University, Dresden, Germany.
Strahlenther Onkol. 1994 Sep;170(9):545-9.
This paper analyses whether the timing of interruptions during radiotherapy of squamous cell carcinomas of the head and neck influences treatment results.
Hundred and ninety-two patients irradiated with curative intent between 1975 and 1985 (63% after surgery and 37 as primary treatment) were analysed with regard to the occurrence, timing, duration and causes of treatment interruptions. In a multivariate analysis, these factors as well as stage, site, extent of surgery etc. were related to 5-year survival rates.
Interruptions of the prescribed course of radiotherapy decreased the survival rate from 61% to 28%. No adverse effect of a break was seen if it occurred during the first 3 weeks whereas survival dropped to 18 to 25% with a break later in the course of radiotherapy.
Timing of treatment interruption in squamous cell carcinomas is a crucial factor determining the chances of tumor cure. The detrimental effect of treatment interruptions increases as treatment progresses. This finding supports the hypothesis that tumor clonogen repopulation accelerates towards the end of radiotherapy of squamous cell carcinomas.
本文分析头颈部鳞状细胞癌放射治疗期间中断治疗的时机是否会影响治疗效果。
对1975年至1985年间接受根治性放疗的192例患者(63%为术后放疗,37%为原发灶放疗)的治疗中断情况、发生时间、持续时间及原因进行分析。在多因素分析中,将这些因素以及分期、部位、手术范围等与5年生存率相关联。
放疗规定疗程的中断使生存率从61%降至28%。如果中断发生在放疗的前三周,则未观察到不良影响,而如果在放疗后期中断,生存率则降至18%至25%。
头颈部鳞状细胞癌治疗中断的时机是决定肿瘤治愈机会的关键因素。随着治疗进展,治疗中断的有害影响会增加。这一发现支持了鳞状细胞癌放疗接近尾声时肿瘤克隆源再增殖加速的假说。